BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Willumsen N, Bager C, Karsdal MA. Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer - A Proof of Concept Study. Transl Oncol 2019;12:693-8. [PMID: 30856553 DOI: 10.1016/j.tranon.2019.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Necula L, Matei L, Dragu D, Pitica I, Neagu A, Bleotu C, Diaconu CC, Chivu-economescu M. Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer. IJMS 2022;23:12415. [DOI: 10.3390/ijms232012415] [Reference Citation Analysis]
2 Pedersen RS, Nissen NI, Jensen C, Thorlacius-Ussing J, Manon-Jensen T, Olesen ML, Langholm LL, Diab HMH, Jorgensen LN, Hansen CP, Chen IM, Johansen JS, Karsdal MA, Willumsen N. Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis. Biomolecules 2022;12:1315. [PMID: 36139154 DOI: 10.3390/biom12091315] [Reference Citation Analysis]
3 Song K, Yu Z, Zu X, Li G, Hu Z, Xue Y. Collagen Remodeling along Cancer Progression Providing a Novel Opportunity for Cancer Diagnosis and Treatment. Int J Mol Sci 2022;23:10509. [PMID: 36142424 DOI: 10.3390/ijms231810509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Adepu S, Ekman S, Leth J, Johansson U, Lindahl A, Skiöldebrand E. Biglycan neo-epitope (BGN262), a Novel biomarker for screening early changes in equine osteoarthritic subchondral bone. Osteoarthritis Cartilage 2022:S1063-4584(22)00797-X. [PMID: 35870736 DOI: 10.1016/j.joca.2022.07.005] [Reference Citation Analysis]
5 Qiao H, Feng Y, Tang H. COL6A6 inhibits the proliferation and metastasis of non-small cell lung cancer through the JAK signalling pathway. Transl Cancer Res 2021;10:4514-22. [PMID: 35116307 DOI: 10.21037/tcr-21-2002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Maneshi P, Mason J, Dongre M, Öhlund D. Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits. Front Cell Dev Biol 2021;9:787485. [PMID: 34901028 DOI: 10.3389/fcell.2021.787485] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Kim MS, Ha SE, Wu M, Zogg H, Ronkon CF, Lee MY, Ro S. Extracellular Matrix Biomarkers in Colorectal Cancer. Int J Mol Sci 2021;22:9185. [PMID: 34502094 DOI: 10.3390/ijms22179185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Lindholm M, Godskesen LE, Manon-Jensen T, Kjeldsen J, Krag A, Karsdal MA, Mortensen JH. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD. Sci Rep 2021;11:14713. [PMID: 34282237 DOI: 10.1038/s41598-021-94321-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Williams L, Layton T, Yang N, Feldmann M, Nanchahal J. Collagen VI as a driver and disease biomarker in human fibrosis. FEBS J 2021. [PMID: 34109754 DOI: 10.1111/febs.16039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
10 Li H, Liu S, Wu S, Li L, Ge R, Cheng CY. Bioactive fragments of laminin and collagen chains: lesson from the testis. Reproduction 2020;159:R111-23. [PMID: 31581125 DOI: 10.1530/REP-19-0288] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Wang PP, Ding SY, Sun YY, Li YH, Fu WN. MYCT1 Inhibits the Adhesion and Migration of Laryngeal Cancer Cells Potentially Through Repressing Collagen VI. Front Oncol 2020;10:564733. [PMID: 33680912 DOI: 10.3389/fonc.2020.564733] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Nissen NI, Kehlet S, Boisen MK, Liljefors M, Jensen C, Johansen AZ, Johansen JS, Erler JT, Karsdal M, Mortensen JH, Høye A, Willumsen N. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab. Sci Rep 2021;11:865. [PMID: 33441622 DOI: 10.1038/s41598-020-79608-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Williams LM, McCann FE, Cabrita MA, Layton T, Cribbs A, Knezevic B, Fang H, Knight J, Zhang M, Fischer R, Bonham S, Steenbeek LM, Yang N, Sood M, Bainbridge C, Warwick D, Harry L, Davidson D, Xie W, Sundstrӧm M, Feldmann M, Nanchahal J. Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300. Proc Natl Acad Sci U S A 2020;117:20753-63. [PMID: 32759223 DOI: 10.1073/pnas.2004281117] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
14 Brett EA, Sauter MA, Machens HG, Duscher D. Tumor-associated collagen signatures: pushing tumor boundaries. Cancer Metab 2020;8:14. [PMID: 32637098 DOI: 10.1186/s40170-020-00221-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
15 Wang J, Pan W. The Biological Role of the Collagen Alpha-3 (VI) Chain and Its Cleaved C5 Domain Fragment Endotrophin in Cancer. Onco Targets Ther 2020;13:5779-93. [PMID: 32606789 DOI: 10.2147/OTT.S256654] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
16 Thorlacius-Ussing J, Manon-Jensen T, Sun S, Leeming DJ, Sand JM, Karsdal M, Willumsen N. Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential. Cancers (Basel) 2020;12:E1510. [PMID: 32527017 DOI: 10.3390/cancers12061510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Brassart-Pasco S, Brézillon S, Brassart B, Ramont L, Oudart JB, Monboisse JC. Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression. Front Oncol 2020;10:397. [PMID: 32351878 DOI: 10.3389/fonc.2020.00397] [Cited by in Crossref: 85] [Cited by in F6Publishing: 95] [Article Influence: 42.5] [Reference Citation Analysis]
18 Brett E, Sauter M, Timmins É, Azimzadeh O, Rosemann M, Merl-Pham J, Hauck SM, Nelson PJ, Becker KF, Schunn I, Lowery A, Kerin MJ, Atkinson M, Krüger A, Machens HG, Duscher D. Oncogenic Linear Collagen VI of Invasive Breast Cancer Is Induced by CCL5. J Clin Med 2020;9:E991. [PMID: 32252260 DOI: 10.3390/jcm9040991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Long R, Liu Z, Li J, Yu H. COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway. Aging (Albany NY) 2019;11:8845-59. [PMID: 31627190 DOI: 10.18632/aging.102300] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
20 Banys-Paluchowski M, Loibl S, Witzel I, Mundhenke C, Lederer B, Solbach C, Karn T, Marmé F, Nekljudova V, Schem C, Stickeler E, Willumsen N, Karsdal MA, Untch M, Müller V. Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial. Cancers (Basel) 2019;11:E1186. [PMID: 31443252 DOI: 10.3390/cancers11081186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
21 Casati M, Costa AS, Capitanio D, Ponzoni L, Ferri E, Agostini S, Lori E. The Biological Foundations of Sarcopenia: Established and Promising Markers. Front Med (Lausanne) 2019;6:184. [PMID: 31457015 DOI: 10.3389/fmed.2019.00184] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]